WO2005042703A3 - Cellules souches placentaires et utilisations associees - Google Patents

Cellules souches placentaires et utilisations associees Download PDF

Info

Publication number
WO2005042703A3
WO2005042703A3 PCT/US2004/034966 US2004034966W WO2005042703A3 WO 2005042703 A3 WO2005042703 A3 WO 2005042703A3 US 2004034966 W US2004034966 W US 2004034966W WO 2005042703 A3 WO2005042703 A3 WO 2005042703A3
Authority
WO
WIPO (PCT)
Prior art keywords
placental stem
stem cells
cells
cardiomyocytes
hepatocytes
Prior art date
Application number
PCT/US2004/034966
Other languages
English (en)
Other versions
WO2005042703A2 (fr
Inventor
Stephen C Strom
Miki Toshio
Original Assignee
M Of Higher Education Universi
Stephen C Strom
Miki Toshio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M Of Higher Education Universi, Stephen C Strom, Miki Toshio filed Critical M Of Higher Education Universi
Priority to CA002543528A priority Critical patent/CA2543528A1/fr
Priority to EP04796030A priority patent/EP1689854A4/fr
Publication of WO2005042703A2 publication Critical patent/WO2005042703A2/fr
Publication of WO2005042703A3 publication Critical patent/WO2005042703A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657Cardiomyocytes; Heart cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0605Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0606Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0619Neurons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/067Hepatocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/069Vascular Endothelial cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • C12N2500/25Insulin-transferrin; Insulin-transferrin-selenium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/11Epidermal growth factor [EGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/117Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/119Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/12Hepatocyte growth factor [HGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/148Transforming growth factor alpha [TGF-a]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/15Transforming growth factor beta (TGF-β)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/385Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00Use of cells in diagnostics
    • C12N2503/02Drug screening
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne de nouvelles cellules souches placentaires ainsi que des méthodes et des compositions permettant des utilisations thérapeutiques de cellules souches placentaires ou de cellules souches placentaires qui ont été amenées à se différencier en un type de tissu différent chez un hôte receveur en quantités suffisantes pour entraîner la production du type cellulaire souhaité, par exemple, des hépatocytes, des cellules nerveuses, des cellules pancréatiques, des cellules endothéliales vasculaires, des cardiomyocytes.
PCT/US2004/034966 2003-10-22 2004-10-22 Cellules souches placentaires et utilisations associees WO2005042703A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002543528A CA2543528A1 (fr) 2003-10-22 2004-10-22 Cellules souches placentaires et utilisations associees
EP04796030A EP1689854A4 (fr) 2003-10-22 2004-10-22 Cellules souches placentaires et utilisations associees

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/691,468 US20040161419A1 (en) 2002-04-19 2003-10-22 Placental stem cells and uses thereof
US10/691,468 2003-10-22

Publications (2)

Publication Number Publication Date
WO2005042703A2 WO2005042703A2 (fr) 2005-05-12
WO2005042703A3 true WO2005042703A3 (fr) 2006-06-22

Family

ID=34549883

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/034966 WO2005042703A2 (fr) 2003-10-22 2004-10-22 Cellules souches placentaires et utilisations associees

Country Status (4)

Country Link
US (1) US20040161419A1 (fr)
EP (1) EP1689854A4 (fr)
CA (1) CA2543528A1 (fr)
WO (1) WO2005042703A2 (fr)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691217B2 (en) 2005-12-29 2014-04-08 Anthrogenesis Corporation Placental stem cell populations
US8895256B2 (en) 2005-10-13 2014-11-25 Anthrogenesis Corporation Immunomodulation using placental stem cells
US8916146B2 (en) 2007-02-12 2014-12-23 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
US8926964B2 (en) 2010-07-13 2015-01-06 Anthrogenesis Corporation Methods of generating natural killer cells
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
US9121007B2 (en) 2010-01-26 2015-09-01 Anthrogenesis Corporatin Treatment of bone-related cancers using placental stem cells
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
US9139813B2 (en) 2001-02-14 2015-09-22 Anthrogenesis Corporation Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
US9149569B2 (en) 2000-12-06 2015-10-06 Anthrogenesis Corporation Treatment of diseases or disorders using placental stem cells
US9175261B2 (en) 2005-12-16 2015-11-03 DePuy Synthes Products, Inc. Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9198938B2 (en) 2008-11-19 2015-12-01 Antrhogenesis Corporation Amnion derived adherent cells
US9216200B2 (en) 2007-09-28 2015-12-22 Anthrogenesis Corporation Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
US9234172B2 (en) 2003-06-27 2016-01-12 DePuy Synthes Products, Inc. Repair and regeneration of ocular tissue using postpartum-derived cells
US9254302B2 (en) 2010-04-07 2016-02-09 Anthrogenesis Corporation Angiogenesis using placental stem cells
US9498501B2 (en) 2003-06-27 2016-11-22 DePuy Synthes Products, Inc. Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473555B2 (en) 2000-04-27 2009-01-06 Geron Corporation Protocols for making hepatocytes from embryonic stem cells
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
JP2006509770A (ja) 2002-11-26 2006-03-23 アンソロジェネシス コーポレーション 細胞治療学、細胞治療単位、およびそれらを利用した治療法
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US7985585B2 (en) 2004-07-09 2011-07-26 Viacyte, Inc. Preprimitive streak and mesendoderm cells
US7622108B2 (en) * 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
WO2005108559A2 (fr) * 2004-04-23 2005-11-17 Bioe, Inc. Cellules précurseurs de plusieurs lignages
JP2007536936A (ja) * 2004-05-14 2007-12-20 ベクトン・ディキンソン・アンド・カンパニー 幹細胞集団および使用方法
JP2006006249A (ja) * 2004-06-28 2006-01-12 Hiroshima Univ 羊膜由来細胞の培養方法及びその利用
AU2012202529B2 (en) * 2004-07-09 2015-04-02 Viacyte, Inc. Preprimitive streak and mesendoderm cells
MX2007001937A (es) 2004-08-16 2007-08-07 Cellres Corp Pte Ltd Aislamiento de celulas madre/progenitoras a partir de membrana anmiotica de cordon umbilical.
CA2580798A1 (fr) * 2004-09-29 2006-04-06 Cellartis Ab Generation de cellules hepatocytaires a partir de souches derivant de blastocytes humains (hbs)
US8017395B2 (en) 2004-12-17 2011-09-13 Lifescan, Inc. Seeding cells on porous supports
CA2592435C (fr) 2004-12-23 2017-03-28 Ethicon, Incorporated Traitement de l'ictus cerebral et d'autres troubles neurodegeneratifs aigus a base de cellules tirees de tissus puerperaux
CN101589137B (zh) * 2005-03-31 2013-06-05 斯丹姆涅恩有限公司 羊膜来源的细胞组合物及其制备方法和用途
US8153430B2 (en) * 2005-03-31 2012-04-10 Stemnion, Inc. Methods related to surgery
US20100028306A1 (en) * 2005-03-31 2010-02-04 Stemnion, Inc. Amnion-Derived Cell Compositions, Methods of Making and Uses Thereof
US20060222634A1 (en) 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
AU2006202209B2 (en) * 2005-05-27 2011-04-14 Lifescan, Inc. Amniotic fluid derived cells
JP2009500297A (ja) * 2005-06-08 2009-01-08 セントカー・インコーポレーテツド 眼の変性についての細胞療法
NZ567334A (en) * 2005-10-13 2012-08-31 Anthrogenesis Corp Production of oligodendrocytes from placenta-derived stem cells
US7534607B1 (en) * 2005-12-27 2009-05-19 Industrial Technology Research Institute Method of producing cardiomyocytes from mesenchymal stem cells
WO2007076522A2 (fr) * 2005-12-28 2007-07-05 Ethicon, Incorporated Traitement de maladies vasculaires peripheriques a l'aide de cellules derivees du post-partum
CA2633775A1 (fr) 2005-12-29 2007-07-12 Anthrogenesis Corporation Co-culture de cellules souches placentaires et cellules souches provenant d'une seconde source
US8871198B2 (en) 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
EP2019858B1 (fr) * 2006-04-17 2012-06-13 BioE LLC Différenciation des cellules progénitrices à lignées multiples en cellules épithéliales respiratoires
US8741643B2 (en) 2006-04-28 2014-06-03 Lifescan, Inc. Differentiation of pluripotent stem cells to definitive endoderm lineage
KR100792184B1 (ko) * 2006-05-12 2008-01-07 재단법인서울대학교산학협력재단 개의 제대혈, 태반 및 개 태아의 심장 유래 다분화능 성체줄기세포, 그 제조방법 및 이를 함유하는 세포 치료제
GB2453074B (en) * 2006-06-02 2011-06-22 Geron Corp Differentiation of primate pluripotent cells to hepatocyte-lineage cells
WO2007146105A2 (fr) * 2006-06-05 2007-12-21 Cryo-Cell International, Inc. Obtention, isolement et cryoconservation de cellules placentaires fœtales
US20080050814A1 (en) * 2006-06-05 2008-02-28 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of fetal placental cells
US20080044848A1 (en) * 2006-06-09 2008-02-21 Heidaran Mohammad A Placental niche and use thereof to culture stem cells
US8475788B2 (en) 2006-06-14 2013-07-02 Stemnion, Inc. Methods of treating spinal cord injury and minimizing scarring
WO2007145889A1 (fr) 2006-06-14 2007-12-21 Stemnion, Inc. Procédés pour traiter une lésion de la moelle épinière et pour minimiser l'étendue de la cicatrisation
WO2008003042A2 (fr) 2006-06-28 2008-01-03 The University Of Medicine And Dentistry Of New Jersey Cellules souches dérivées d'amnios et utilisations de celles-ci
US7993918B2 (en) * 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
AU2007309447B2 (en) * 2006-10-23 2014-04-03 Celularity Inc. Methods and compositions for treatment of bone defects with placental cell populations
EP2118267B1 (fr) 2007-01-17 2017-03-15 Noveome Biotherapeutics, Inc. Nouveaux procédés pour moduler des réponses inflammatoires et/ou immunitaires
CN101688177A (zh) 2007-02-12 2010-03-31 人类起源公司 来自贴壁胎盘干细胞的肝细胞和软骨细胞;以及cd34+、cd45-胎盘干细胞富集的细胞群
EP2139497B1 (fr) * 2007-04-13 2013-11-06 Stemnion, INC. Procédés pour le traitement d'une lésion et d'une maladie du système nerveux
JP5567476B2 (ja) * 2007-05-28 2014-08-06 モナッシュ ユニバーシティ 慢性肺疾患の治療
CA2688504A1 (fr) 2007-06-18 2008-12-24 Children's Hospital & Research Center At Oakland Procede permettant d'isoler du placenta des cellules souches et progenitrices
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
CN101835479A (zh) * 2007-07-25 2010-09-15 佰欧益有限公司 多系祖细胞分化为软骨细胞
DK2185693T3 (da) 2007-07-31 2019-09-23 Lifescan Inc Differentiering af humane embryoniske stamceller
US8529888B2 (en) 2007-09-19 2013-09-10 Pluristem Ltd. Adherent cells from adipose or placenta tissues and use thereof in therapy
JP5710264B2 (ja) 2007-11-27 2015-04-30 ライフスキャン・インコーポレイテッドLifescan,Inc. ヒト胚性幹細胞の分化
US10066203B2 (en) 2008-02-21 2018-09-04 Janssen Biotech Inc. Methods, surface modified plates and compositions for cell attachment, cultivation and detachment
US8623648B2 (en) 2008-04-24 2014-01-07 Janssen Biotech, Inc. Treatment of pluripotent cells
EP2294187A2 (fr) * 2008-05-21 2011-03-16 BioE LLC Différenciation de cellules progénitrices de multiples lignées en cellules pancréatiques
WO2010002846A1 (fr) 2008-06-30 2010-01-07 Centocor Ortho Biotech Inc. Différenciation de cellules souches pluripotentes
CA2729734A1 (fr) * 2008-06-30 2010-01-07 Centocor Ortho Biotech Inc. Differenciation de cellules souches pluripotentes
US20100028307A1 (en) * 2008-07-31 2010-02-04 O'neil John J Pluripotent stem cell differentiation
US8828376B2 (en) 2008-08-20 2014-09-09 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
MX339624B (es) 2008-08-20 2016-06-02 Anthrogenesis Corp Composiciones mejoradas de celulas y metodos para preparar las mismas.
EP2633861B1 (fr) 2008-08-22 2015-08-12 Anthrogenesis Corporation Procédés et compositions pour le traitement de déficits osseux au moyen de populations de cellules placentaires
WO2010043076A1 (fr) * 2008-10-17 2010-04-22 宁夏医科大学附属医院 Procédé d'élaboration d'une banque de cellules placentaires mésenchymateuses humaines à applications cliniques
US9012218B2 (en) * 2008-10-31 2015-04-21 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
RU2522001C2 (ru) * 2008-10-31 2014-07-10 Сентокор Орто Байотек Инк. Дифференцирование человеческих эмбриональных стволовых клеток в линию панкреатических эндокринных клеток
CN102307991B (zh) 2008-11-20 2017-08-15 森托科尔奥索生物科技公司 微载体上的多能干细胞培养
CA2744227C (fr) * 2008-11-20 2018-10-02 Centocor Ortho Biotech Inc. Procedes et compositions pour adhesion cellulaire et culture sur des substrats plans
AU2009324641A1 (en) * 2008-12-10 2011-07-28 University Of Louisville Research Foundation, Inc. Somatic cell-derived pluripotent cells and methods of use therefor
CN101748096B (zh) * 2008-12-17 2013-03-13 北京汉氏联合生物技术有限公司 亚全能干细胞、其制备方法及其用途
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
WO2010071864A1 (fr) 2008-12-19 2010-06-24 Ethicon, Incorporated Traitement des poumons et des maladies et troubles pulmonaires
US8771677B2 (en) 2008-12-29 2014-07-08 Vladimir B Serikov Colony-forming unit cell of human chorion and method to obtain and use thereof
EP2411504B1 (fr) 2009-03-26 2017-05-10 DePuy Synthes Products, Inc. Cellules provenant de tissus de cordon ombilical humain pour la thérapie de la maladie d'alzheimer
FI20095409A0 (fi) * 2009-04-14 2009-04-14 Helsingin Yliopisto Soluviljelysupplementti
US8647617B2 (en) 2009-07-13 2014-02-11 Stemnion, Inc. Methods for modulating inflammatory and/or immune responses
JP5819826B2 (ja) * 2009-07-20 2015-11-24 ヤンセン バイオテツク,インコーポレーテツド ヒト胚性幹細胞の分化
SG177481A1 (en) 2009-07-20 2012-02-28 Janssen Biotech Inc Differentiation of human embryonic stem cells
ES2693088T3 (es) * 2009-07-20 2018-12-07 Janssen Biotech, Inc. Diferenciación de células madre embriónicas humanas
ES2633648T3 (es) * 2009-12-23 2017-09-22 Janssen Biotech, Inc. Diferenciación de células madre embrionarias humanas
CN102741395B (zh) 2009-12-23 2016-03-16 詹森生物科技公司 人胚胎干细胞的分化
MX358451B (es) 2010-03-01 2018-08-20 Janssen Biotech Inc Métodos para purificar células derivadas de células madre pluripotenciales.
WO2011127113A1 (fr) 2010-04-08 2011-10-13 Anthrogenesis Corporation Traitement de la sarcoïdose au moyen de cellules souches du sang placentaire
MX351515B (es) 2010-05-12 2017-10-17 Janssen Biotech Inc Diferenciacion de celulas madre embrionarias humanas.
US8454957B2 (en) 2010-06-17 2013-06-04 Stemnion, Inc. Methods for treating coagulation disorders
CN101914488B (zh) * 2010-08-04 2014-08-27 北京科润维德生物技术有限责任公司 将人羊膜间充质细胞诱导分化成胰岛分泌细胞的方法
EP2611910B1 (fr) 2010-08-31 2018-01-17 Janssen Biotech, Inc. Différenciation de cellules souches embryonnaires humaines
PL2611907T3 (pl) 2010-08-31 2016-11-30 Różnicowanie pluripotencjalnych komórek macierzystych
BR112013004616A2 (pt) 2010-08-31 2016-07-05 Janssen Biotech Inc diferenciação das células tronco embrionárias humanas
US8895291B2 (en) 2010-10-08 2014-11-25 Terumo Bct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
US8574899B2 (en) 2010-12-22 2013-11-05 Vladimir B Serikov Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
EP3443968A1 (fr) 2011-06-01 2019-02-20 Celularity, Inc. Traitement de la douleur à l'aide de cellules souches placentaires
WO2013055476A1 (fr) 2011-09-09 2013-04-18 Anthrogenesis Corporation Traitement de la sclérose latérale amyotrophique au moyen de cellules souches placentaires
AU2012355698B2 (en) 2011-12-22 2018-11-29 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into single hormonal insulin positive cells
SG11201403465PA (en) 2011-12-23 2014-10-30 Atrm Llc Detection of human umbilical cord tissue-derived cells
MX354775B (es) 2012-03-07 2018-03-20 Janssen Biotech Inc Medios definidos para la expansion y el mantenimiento de celulas madre pluripotentes.
KR102667288B1 (ko) 2012-06-08 2024-05-17 얀센 바이오테크 인코포레이티드 인간 배아 줄기 세포의 췌장 내분비 세포로의 분화
AU2013248265B2 (en) * 2012-11-08 2018-11-01 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
EP2938724B1 (fr) 2012-12-31 2020-10-28 Janssen Biotech, Inc. Culture de cellules souches embryonnaires humaines à l'interface air-liquide en vue de la différenciation en cellules endocrines pancréatiques
CN105073979B (zh) 2012-12-31 2020-03-06 詹森生物科技公司 使用hb9调节子使人胚胎干细胞分化为胰腺内分泌细胞的方法
RU2018108090A (ru) 2012-12-31 2019-02-25 Янссен Байотек, Инк. Суспендирование и кластеризация плюрипотентных клеток человека с целью их дифференцировки в панкреатические эндокринные клетки
EP3622960A1 (fr) 2013-02-05 2020-03-18 Celularity, Inc. Cellules tueuses naturelles placentaires
WO2014129792A1 (fr) * 2013-02-20 2014-08-28 사회복지법인 삼성생명공익재단 Composition pour le traitement de maladies inflammatoires du cerveau comprenant une cellule souche comme principe actif
EP2968402B1 (fr) 2013-03-13 2020-07-15 Noveome Biotherapeutics, Inc. Dispositifs medicaux avec un revetement contenant accs
US9511119B2 (en) 2013-03-15 2016-12-06 NuTech Spine, Inc. Preparations containing hepatocyte growth factor and hyaluronic acid and methods of making and using same
AU2014239954B2 (en) * 2013-03-15 2020-07-16 The Jackson Laboratory Isolation of non-embryonic stem cells and uses thereof
US20160193250A1 (en) * 2013-05-30 2016-07-07 Cells For Cells Chorion-derived mscs cells and conditioned media as inducer for angiogenesis application for the treatment of cardiac degeneration.
WO2015073918A1 (fr) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expansion de cellules dans un bioréacteur
WO2015148704A1 (fr) 2014-03-25 2015-10-01 Terumo Bct, Inc. Remplacement passif de milieu
WO2015175776A1 (fr) 2014-05-14 2015-11-19 NuTech Medical, Inc. Préparations de membrane placentaire, et leurs procédés de fabrication et d'utilisation pour régénérer un cartilage et des disques intervertébraux de la colonne vertébrale
WO2015175307A1 (fr) 2014-05-16 2015-11-19 Janssen Biotech, Inc. Utilisation de petites molécules pour améliorer l'expression du gène mafa dans des cellules endocrines pancréatiques
EP3198006B1 (fr) 2014-09-26 2021-03-24 Terumo BCT, Inc. Alimentation programmée
WO2017004592A1 (fr) 2015-07-02 2017-01-05 Terumo Bct, Inc. Croissance cellulaire à l'aide de stimuli mécaniques
CN108367028A (zh) * 2015-09-15 2018-08-03 细胞结构公司 使用胎盘细胞治疗糖尿病性周围神经病变
CN106609258A (zh) * 2015-10-23 2017-05-03 江苏齐氏生物科技有限公司 一种大鼠鼻粘膜上皮细胞分离及培养方法
MA45479A (fr) 2016-04-14 2019-02-20 Janssen Biotech Inc Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
CN109415696A (zh) 2016-05-25 2019-03-01 泰尔茂比司特公司 细胞扩增
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
KR102360990B1 (ko) 2016-07-29 2022-02-08 고쿠리츠다이가쿠호진 도호쿠다이가쿠 혈관장해의 예방 또는 치료제
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3656842A1 (fr) 2017-03-31 2020-05-27 Terumo BCT, Inc. Expansion de cellules
WO2019040790A1 (fr) * 2017-08-23 2019-02-28 Merakris Therapeutics, Llc Compositions contenant des composants amniotiques et leurs procédés de préparation et d'utilisation
KR102224273B1 (ko) * 2019-10-10 2021-03-08 고려대학교 산학협력단 줄기세포 유래 성숙 심근세포 및 이를 이용한 심혈관 질환 모델

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999020741A1 (fr) * 1997-10-23 1999-04-29 Geron Corporation Procedes et matieres utiles pour la croissance de cellules souches primordiales de primate
WO2000073421A2 (fr) * 1999-06-02 2000-12-07 Lifebank Services, L.L.C. Methodes d'isolement, de cryopreservation, et d'utilisation therapeutique de cellules epitheliales amniotiques humaines
US20020151053A1 (en) * 2000-01-11 2002-10-17 Carpenter Melissa K. Direct differentiation of human pluripotent stem cells and characterization of differentiated cells
WO2003042405A2 (fr) * 2001-11-15 2003-05-22 Children's Medical Center Corporation Techniques d'isolation, de developpement et de differenciation de cellules souches provenant de villosites choriales, de liquide amniotique ainsi que de placenta et applications therapeutiques
US20030180269A1 (en) * 2002-02-13 2003-09-25 Hariri Robert J. Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
GB8803697D0 (en) * 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
ATE221382T1 (de) * 1993-05-24 2002-08-15 Ximerex Inc Die erzeugung von toleranz gegen fremdtransplantate durch tolerogenese mit hilfe von ersatzlebewesen
WO1996015230A2 (fr) * 1994-11-16 1996-05-23 Amgen Inc. Utilisation du facteur des cellules souches et du recepteur de l'interleukine 6 soluble dans le developpement ex vivo des cellules multipotentielles hematopoietiques
US6117676A (en) * 1995-07-27 2000-09-12 Srl, Inc. Transfected human amniotic cells and method for producing a gene product
CA2324208C (fr) * 1998-03-18 2009-06-30 Massachusetts Institute Of Technology Ensemble de micro-tissus et de micro-organes vascularises et perfuses
US6395546B1 (en) * 2000-02-01 2002-05-28 Neurogeneration, Inc. Generation of dopaminergic neurons from human nervous system stem cells
EP1288293A1 (fr) * 2001-08-30 2003-03-05 Norio Sakuragawa Cellules souches neuronales humaines originaires d'une couche de cellules mesenchymateuses amniotiques humaines

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999020741A1 (fr) * 1997-10-23 1999-04-29 Geron Corporation Procedes et matieres utiles pour la croissance de cellules souches primordiales de primate
WO2000073421A2 (fr) * 1999-06-02 2000-12-07 Lifebank Services, L.L.C. Methodes d'isolement, de cryopreservation, et d'utilisation therapeutique de cellules epitheliales amniotiques humaines
US20020151053A1 (en) * 2000-01-11 2002-10-17 Carpenter Melissa K. Direct differentiation of human pluripotent stem cells and characterization of differentiated cells
WO2003042405A2 (fr) * 2001-11-15 2003-05-22 Children's Medical Center Corporation Techniques d'isolation, de developpement et de differenciation de cellules souches provenant de villosites choriales, de liquide amniotique ainsi que de placenta et applications therapeutiques
US20030180269A1 (en) * 2002-02-13 2003-09-25 Hariri Robert J. Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9149569B2 (en) 2000-12-06 2015-10-06 Anthrogenesis Corporation Treatment of diseases or disorders using placental stem cells
US9139813B2 (en) 2001-02-14 2015-09-22 Anthrogenesis Corporation Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US9234172B2 (en) 2003-06-27 2016-01-12 DePuy Synthes Products, Inc. Repair and regeneration of ocular tissue using postpartum-derived cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US9498501B2 (en) 2003-06-27 2016-11-22 DePuy Synthes Products, Inc. Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US8895256B2 (en) 2005-10-13 2014-11-25 Anthrogenesis Corporation Immunomodulation using placental stem cells
US9539288B2 (en) 2005-10-13 2017-01-10 Anthrogenesis Corporation Immunomodulation using placental stem cells
US9175261B2 (en) 2005-12-16 2015-11-03 DePuy Synthes Products, Inc. Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
US9585918B2 (en) 2005-12-28 2017-03-07 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
US8691217B2 (en) 2005-12-29 2014-04-08 Anthrogenesis Corporation Placental stem cell populations
US8916146B2 (en) 2007-02-12 2014-12-23 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
US9216200B2 (en) 2007-09-28 2015-12-22 Anthrogenesis Corporation Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
US9198938B2 (en) 2008-11-19 2015-12-01 Antrhogenesis Corporation Amnion derived adherent cells
US9121007B2 (en) 2010-01-26 2015-09-01 Anthrogenesis Corporatin Treatment of bone-related cancers using placental stem cells
US9254302B2 (en) 2010-04-07 2016-02-09 Anthrogenesis Corporation Angiogenesis using placental stem cells
US9464274B2 (en) 2010-07-13 2016-10-11 Anthrogenesis Corporation Methods of generating natural killer cells
US8926964B2 (en) 2010-07-13 2015-01-06 Anthrogenesis Corporation Methods of generating natural killer cells
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules

Also Published As

Publication number Publication date
WO2005042703A2 (fr) 2005-05-12
US20040161419A1 (en) 2004-08-19
CA2543528A1 (fr) 2005-05-12
EP1689854A2 (fr) 2006-08-16
EP1689854A4 (fr) 2007-01-24

Similar Documents

Publication Publication Date Title
WO2005042703A3 (fr) Cellules souches placentaires et utilisations associees
WO2003089619A3 (fr) Cellules souches placentaires et utilisations
WO2007030743A3 (fr) Implants cochleaires contenant des cellules biologiques et utilisations de ces dernieres
WO2005030121A3 (fr) Composes, compositions et procedes
WO2006071777A3 (fr) Reparation et regeneration de tissus mous au moyen de cellules derivees du post-partum et produits cellulaires
WO2008057459A3 (fr) Antagonistes de pcsk9
WO2008057458A3 (fr) Antagonistes de pcsk9
WO2008133647A3 (fr) Antagonistes de pcsk9
WO2007065010A3 (fr) Composes anti-angiogenese
WO2005001079A3 (fr) Reparation et regeneration des tissus mous a l'aide de cellules provenant de tissus post-partum
WO2005085422A8 (fr) Cellules souches adultes et leurs utilisations
WO2007067682A3 (fr) Modification in vivo de surfaces cellulaires
WO2007149861A3 (fr) Réparation de tissu mou et régénération à l'aide des produits de cellules souches
EP1302536A3 (fr) Cellules souches embryonnaires et cellules progénitrices neuronales dérivées de celles-ci
WO2003080801A3 (fr) Cellules souches stromales issues de tissu adipeux, utiles pour la modification de tissus et de vaisseaux
WO2007030652A3 (fr) Methodes et compositions pour cultiver des cellules souches adipeuses
WO2006053227A3 (fr) Composes modulateurs de la il-12
WO2005099770A3 (fr) Micro-arn d'ilot pancreatique et methodes permettant d'inhiber ce dernier
WO2006018836A3 (fr) Constructions d'acides nucleiques et cellules, et methodes faisant appel a ces dernieres pour modifier la fonction electrophysiologique de tissus excitables
WO2005118824A8 (fr) Methodes et compositions inhibant l'expression genique
EP1627047A4 (fr) Methodes permettant de faciliter la recuperation de fonctions de cellules souches endogenes, implantees ou transplantees au moyen d'un acide hyaluronique de poids moleculaire eleve
WO2006060680A3 (fr) Variants de la proteine mda-7 presentant une activite antiproliferative
WO2006063055A3 (fr) Conjugues enzymatiques utilises en tant qu'agents detoxifiants
WO2003091398A3 (fr) Compositions et techniques d'apport de cellules embryonnaires
WO2005047494A3 (fr) Cellules souches convenant a la transplantation: preparation et compositions pharmaceutiques contenant ces cellules

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2543528

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004796030

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004796030

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004796030

Country of ref document: EP